AT-007
Modify Date: 2024-01-09 11:26:18
AT-007 structure
|
Common Name | AT-007 | ||
|---|---|---|---|---|
| CAS Number | 2170729-29-8 | Molecular Weight | 425.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H10F3N3O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AT-007AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM[1][2]. |
| Name | AT-007 |
|---|
| Description | AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM[1][2]. |
|---|---|
| Target |
IC50: 100 pM (Aldose Reductase)[2] |
| References |
[2]. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. APPLIED THERAPEUTICS, INC. |
| Molecular Formula | C17H10F3N3O3S2 |
|---|---|
| Molecular Weight | 425.40 |